Journal of Molecular Biomarkers and Clinical Trials
Biomarkers for the Neglected Chagas Disease: How Remarkable!
Published on: 2016-05-09
Chagas disease or American trypanosomiasis, caused by the etiological agent Trypanosoma cruzi, affects at least 8 million people in Central and South America. Morbidity is relatively high. The acute phase is followed by an asymptomatic phase, but roughly 30% of infected patients change to a symptomatic, chronic phase characterized by either severe cardiac or digestive forms.